Pediatrix Medical Group: EVP and Chief Physician Executive Curtis Pickert to depart January 31, 2025
Pediatrix disclosed that Dr. Curtis B. Pickert, its Executive Vice President and Chief Physician Executive and a former Chief Operating Officer, will transition out of his role effective January 31, 2025. The company notified him on November 29, 2024, and the departure is treated as a termination without Cause under his employment agreement, with benefits payable after he signs a general release. The filing does not describe a successor or any financial impact.
Key points
- Dr. Curtis B. Pickert's transition is effective January 31, 2025.
- The company notified Dr. Pickert of the transition on November 29, 2024.
- The departure is a termination without Cause under his Second Amended and Restated Employment Agreement dated April 26, 2023.
- Benefits are payable only after Dr. Pickert signs a general release of claims in favor of the company.
The filing
Written by AI on Nov 8, 2026, 6:56 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on December 05, 2024.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.